Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00603850 · ClinicalTrials.gov registry record

Testing the Effectiveness of the Interactive Tutorial of the Home Macular Perimeter (HMP)

A clinical trial, sponsored by Notal Vision.

Completed
Registry status
25
Enrollment target

NCT00603850: Completed study, sponsored by Notal Vision.

NCT00603850 is a clinical trial that has completed, run by Notal Vision. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00603850 has completed, sponsored by Notal Vision.

COMPLETED
Registry status
25 participants
Enrollment target

Study Summary

Demonstrate the ability of the current interactive tutorial and 1-800 support to teach an AMD patient to use the HMP device.

Interventions

  • DEVICE ForeseeHome

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2008-01
Est. Completion 2008-04
Notal Vision

11 total trials

What the finished NCT00603850 record still lists

NCT00603850 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which ForeseeHome is the first listed.

NCT00603850 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00603850 about?

NCT00603850 is a clinical study titled "Testing the Effectiveness of the Interactive Tutorial of the Home Macular Perimeter (HMP)". Demonstrate the ability of the current interactive tutorial and 1-800 support to teach an AMD patient to use the HMP device.

What is the current status of trial NCT00603850?

This trial is currently completed. The enrollment target is 25 participants. The study started on 2008-01. Estimated completion is 2008-04.

What interventions are being tested in trial NCT00603850?

The interventions under investigation include: ForeseeHome (DEVICE).

Who is sponsoring clinical trial NCT00603850?

This trial is sponsored by Notal Vision, which has 11 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01166854 · 25 participants

    Characterization of Familial Myopathy and Paget Disease of Bone

  • NCT01913106 · 25 participants · Phase 1

    HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer

  • NCT02138669 · 25 participants · NA

    Intacs Prescription Inserts for Keratoconus Patients

  • NCT02174549 · 25 participants · Phase 1

    Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00603850, the US trial registry maintained by the National Library of Medicine. NCT00603850 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.